Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer.

COVID COVID-19 Coronavirus Mixed methods Prostate cancer Social media

Journal

European urology open science
ISSN: 2666-1683
Titre abrégé: Eur Urol Open Sci
Pays: Netherlands
ID NLM: 101771568

Informations de publication

Date de publication:
Mar 2021
Historique:
accepted: 16 12 2020
entrez: 2 8 2021
pubmed: 3 8 2021
medline: 3 8 2021
Statut: epublish

Résumé

The COVID-19 pandemic dramatically impacted society and health care on a global scale. To capture the lived experience of patients with prostate cancer and family members/caregivers during the COVID-19 pandemic, we performed a mixed-methods study of posts to two online networks. We compared all 6187 posts to the Inspire Us TOO Prostate Cancer online support and discussion community from December 2019 to April 2020, to 6926 posts from the same interval in 2019, applying a linguistic ethnography method. A similar analysis was performed using data from the Reddit discussion website (246 posts from 2019 and 260 posts from 2020). Manual qualitative analysis was performed for all 207 posts that mentioned COVID, COVID-19, or coronavirus. The computational linguistic ethnography analysis revealed a more collective tone in 2020, with increased concern about death. Our qualitative analysis showed that patients with prostate cancer and caregivers have concern about a variety of COVID-19-related impacts on care, including delays in testing and treatment. There was also substantial concern about the impact of having cancer on COVID-19 risk and access to COVID-19 care. Misinformation was present in 7% of COVID-19-related posts. In conclusion, online networks provide a useful source of real-world data from patients and their families, and analysis of these data highlighted a substantial impact of COVID-19 on prostate cancer care. We performed a study of online posts by patients with prostate cancer and their families on their perspectives about COVID-19. Concerns about the impact of COVID-19 included worry about delays in testing and treatment. Our research also revealed misinformation in COVID-19-related posts.

Identifiants

pubmed: 34337497
doi: 10.1016/j.euros.2020.12.008
pii: S2666-1683(20)36386-2
pmc: PMC8317896
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-4

Informations de copyright

© 2020 The Authors.

Références

Eur Urol. 2020 Aug;78(2):265-275
pubmed: 32507625

Auteurs

Stacy Loeb (S)

Department of Urology, New York University and Manhattan Veterans Affairs, New York, NY, USA.
Department of Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA.

Rada Mihalcea (R)

Department of Computer Science, University of Michigan, Ann Arbor, MI, USA.

Veronica Perez-Rosas (V)

Department of Computer Science, University of Michigan, Ann Arbor, MI, USA.

Alex Xu (A)

Department of Urology, New York University and Manhattan Veterans Affairs, New York, NY, USA.

Jacob Taylor (J)

Department of Urology, New York University and Manhattan Veterans Affairs, New York, NY, USA.

Nataliya Byrne (N)

Department of Urology, New York University and Manhattan Veterans Affairs, New York, NY, USA.
Department of Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA.

Dawn Walter (D)

Department of Urology, New York University and Manhattan Veterans Affairs, New York, NY, USA.
Department of Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA.

Marina Ness (M)

Inspire, Arlington, VA, USA.

Rebecca Robbins (R)

Division of Sleep and Circadian Disorders, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

Sylvia Zhang (S)

Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

Trevor Killeen (T)

Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

Divya Natesan (D)

Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

Hala T Borno (HT)

Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

Classifications MeSH